New articles

13.11.2021

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension

Manukyan M. A., Falkovskaya A. Y., Mordovin V. F., Ryabova T. R., Zyubanova I. V., Gusakova A. M., Suslova T. E.
10.14341/DM12732
BACKGROUND: It is expected that a steady increase in the incidence of diabetes and resistant hypertension (RHTN), along with an increase in life expec...
13.11.2021

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon

Vitebskaya A. V., Shreder E. V., Popovich A. V., Pisareva E. A.
10.14341/DM12431
Backgraund: Children with type 1 diabetes mellitus (T1DM) need more insulin late in the evening (reverse dawn phenomenon (RDP)), and adolescents need ...
13.11.2021

The role of iron metabolism indicators in predicting gestational diabetes mellitus

Torosyan A. O., Loginova E. V., Gagaev C. G.
10.14341/DM12502
Iron (Fe) deficiency and hyperglycaemia are both widely found throughout the world among pregnant women. According to the latest data from the America...
13.11.2021

Assessment of the physical development and metabolic status of children born to women with gestational diabetes

Deynega (Masel) A. S., Liskina A. S., Valieva S. A., Nikitina I. L.
10.14341/DM12463
Backgraund: Gestational diabetes mellitus (GDM) is one of the most common metabolic disorders found during pregnancy. Currently, it is relevant not on...
13.11.2021

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies

Kononenko I. V., Smirnova O. M.
10.14341/DM12768
Sulfonylureas are widely prescribed all over the world, mainly because of their high effectiveness. At the same time, the heterogeneity of the group i...
13.11.2021

Transcription factor 7-like 2 (TCF7L2): a culprit gene in Type 2 Diabetes Mellitus

Jan A. , Jan H. , Ullah Z.
10.14341/DM12313
The genetics of Type 2 diabetes a complex metabolic disorder, characterized by decreased insulin secretion and insulin resistance resulting in impaire...
13.11.2021

Some mechanisms of inflammation development in type 2 diabetes mellitus

Bochkareva L. A., Nedosugova L. V., Petunina N. A., Теlnova M. Е., Goncharova E. V.
10.14341/DM12746
Inflammation plays a key role in the development and progression of type 2 diabetes (T2DM), a disease characterized by peripheral insulin resistance a...
13.11.2021

Effect of oral antihyperglycemic drugs on purine metabolism

Panevin T. S.
10.14341/DM12756
Gout and diabetes mellitus are metabolic diseases, the pathogenesis of which is based on an excess of organic molecules in the body, in the first case...
13.11.2021

Neovascular glaucoma in patients with diabetes mellitus — the current state of the problem

Biletskaya V. A., Lipatov D. V., Frolov M. A., Kazakova K. A.
10.14341/DM12490
Today, diabetes is one of the leading medical and social problems. This is due to a pandemic increase in the development of the disease. Eye complicat...
12.11.2021

Assessment of the prevalence of anemia in patients with primary hyperparathyroidism: a single-center observational study

Miliutina A. P., Gorbacheva A. M., Ajnetdinova A. R., Eremkina A. K., Mokrysheva N. G.
10.14341/probl12807
BACKGROUND: The combination of primary hyperparathyroidism (PHPT) with anemia was first described in 1931. It remains unclear whether PHPT is the dire...